BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. METHODS: Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month-11 months after exposure). RESULTS: Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre andgt; or = 80) after 2 weeks and 100%...
Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing a...
The differential antibody response measured by the commonly used hemagglutination inhibition (HI) an...
Objectives: The long-term dynamics of antibody responses in patients with influenza A(H7N9) vir...
Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected pat...
BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
<p>*MN = standard microneutralization test; *H5pp = pseudotyped H5 particles-based microneutraliza...
<p>The hNPCs supported H5N1 virus infection as determined by a statistical significant increase of v...
BackgroundThe kinetics of the antibody response during severe influenza are not well documented.Meth...
Background: Most reported human H5N1 viral infections have been severe and were detected after hosp...
Background: Most reported human H5N1 viral infections have been severe and were detected after hosp...
<p>End-point virus neutralization titers of samples collected after the H5N1 subunit vaccine boost a...
BACKGROUND: Most reported human H5N1 viral infections have been severe and were detected after hospi...
Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing a...
The differential antibody response measured by the commonly used hemagglutination inhibition (HI) an...
Objectives: The long-term dynamics of antibody responses in patients with influenza A(H7N9) vir...
Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected pat...
BACKGROUND: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-...
<p>*MN = standard microneutralization test; *H5pp = pseudotyped H5 particles-based microneutraliza...
<p>The hNPCs supported H5N1 virus infection as determined by a statistical significant increase of v...
BackgroundThe kinetics of the antibody response during severe influenza are not well documented.Meth...
Background: Most reported human H5N1 viral infections have been severe and were detected after hosp...
Background: Most reported human H5N1 viral infections have been severe and were detected after hosp...
<p>End-point virus neutralization titers of samples collected after the H5N1 subunit vaccine boost a...
BACKGROUND: Most reported human H5N1 viral infections have been severe and were detected after hospi...
Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing a...
The differential antibody response measured by the commonly used hemagglutination inhibition (HI) an...
Objectives: The long-term dynamics of antibody responses in patients with influenza A(H7N9) vir...